Literature DB >> 9566608

Vasopressinergic, oxytocinergic, and somatostatinergic neuronal activity after adrenalectomy and immobilization stress.

R E Franco-Bourland1.   

Abstract

Twenty days after bilateral adrenalectomy (ADX) or immediately after the last of three 6-h long immobilization periods, the levels of hypothalamic and neurohypophyseal L-[35S]Cys-labeled arginine vasopressin (AVP), oxytocin (OT), and somatostatin-14 (SRIF) (only stressed animals) were measured simultaneously in male Wistar rats, after third ventricular administration of the labeled precursor, via guide-cannulae. The acetic acid-extracted labeled peptide fractions were purified by two sequential HPLC steps. After a 4 h period of labeling, only L-[35S]Cys-AVP was selectively increased in the hypothalami of ADX-ized rats, compared to the sham-operated animals, possibly reflecting a significant activation of the paraventricular parvocellular (PVC) AVP/corticotropin-releasing factor (CRF) neurons. The increased accumulation of neurohypophyseal L-[35S]Cys-labeled AVP and OT in these animals, without changes in the endogenous levels of these peptides, as measured by UV absorbance, also suggests a moderate activation of the magnocellular (MGC) AVP and OT neurons, as a consequence of adrenal insufficiency. In response to immobilization stress, levels of L-[35S]Cys-OT were selectively increased in the hypothalami and corresponding neurohypophyses, 2 h and 4 h after receiving the label, concomitantly with a statistically significant reduction in the stores of OT in the neural lobes. AVP and SRIF biosynthesis remained unaffected by immobilization; the neurohypophyseal AVP stores likewise remained unchanged. These observations suggest the selective activation of MGC-OT neurons in response to chronic immobilization stress. Selective increases in hypothalamic L-[35S]Cys-AVP in ADX-ized rats, and in hypothalamic L-[35S]Cys-OT in chronically stress-immobilized rats, are presented as a measure of PVC-AVP/CRF and MGC-OT neuronal activation, respectively.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566608     DOI: 10.1023/a:1022447023840

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  The effects of adrenalectomy and glucocorticoid replacement on vasopressin and vasopressin-neurophysin in the zona externa of the median eminence of the rat.

Authors:  M A Stillman; L D Recht; S L Rosario; S M Seif; A G Robinson; E A Zimmerman
Journal:  Endocrinology       Date:  1977-07       Impact factor: 4.736

2.  Immunoneutralization of oxytocin attenuates stress-induced corticotropin secretion in the rat.

Authors:  D M Gibbs
Journal:  Regul Pept       Date:  1985-11-28

3.  The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis.

Authors:  F Vandesande; K Dierickx; J De Mey
Journal:  Cell Tissue Res       Date:  1977-06-13       Impact factor: 5.249

4.  Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress.

Authors:  D M Gibbs
Journal:  Life Sci       Date:  1984-07-30       Impact factor: 5.037

5.  High concentrations of oxytocin in hypophysial portal plasma.

Authors:  D M Gibbs
Journal:  Endocrinology       Date:  1984-04       Impact factor: 4.736

6.  [35S]cysteine labeled peptides transported to the neurohypophyses of adrenalectomized, lactating, and Brattleboro rats.

Authors:  J T Russell; M J Brownstein; H Gainer
Journal:  Brain Res       Date:  1980-11-10       Impact factor: 3.252

7.  Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat.

Authors:  P E Sawchenko; L W Swanson; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

8.  Actions of neurohypophysial peptides on pancreatic hormone release.

Authors:  B E Dunning; J H Moltz; C P Fawcett
Journal:  Am J Physiol       Date:  1984-01

9.  Central modulation of immunoreactive arginine vasopressin and oxytocin secretion into the hypophysial-portal circulation by corticotropin-releasing factor.

Authors:  P M Plotsky; T O Bruhn; S Otto
Journal:  Endocrinology       Date:  1985-04       Impact factor: 4.736

10.  Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture.

Authors:  U I Richardson; A Schonbrunn
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

View more
  2 in total

1.  Enhanced expressions of arginine vasopressin (Avp) in the hypothalamic paraventricular and supraoptic nuclei of type 2 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Yo Na Kim; Il Yong Kim; Son-Il Pak; In Se Lee; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2007-10-17       Impact factor: 3.996

Review 2.  Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes.

Authors:  Andreas Stengel; Jean Rivier; Yvette Taché
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.